| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |